Insider trade

Officer sold ~$296K of CORT shares in the open market

Traded Mar 4, 2026 · Filed Mar 7, 2026

Why it stands out

Corcept Therapeutics's Chief Development Officer sold $296K of Corcept Therapeutics shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Officer$100K–$500KPre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$296,346

Shares × reported transaction price

Timing vs results

8 days after results of Feb 24, 2026, 57 days before results of Apr 30, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	−5.3%	−1.4%	−4.0%
30 days	+23.2%	−0.3%	+23.5%
90 days	+115.7%	+9.0%	+106.8%
180 days	+235.3%	+12.9%	+222.4%

Past results only. Not a forecast.

This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction.
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $35.97 to $36.05 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025 and 498 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Scheduled in advance6mo ago

7mo ago

Gift or transfer — classified separately from trades.

7mo ago

Derivative exercise or conversion — not an open-market buy.